- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- Science Education Progress
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
R&D Funding That Isn’t for R&D
The recently unveiled blog at the new Scientists and Engineers for America Action Fund website has a column from Gerald Epstein questioning a $2 billion request in the FY2009 budget for the Department of Homeland Security. He determines that the request is for an already-funded multi-agency bioshield project that would stockpile medical supplies for use in the event of a bioterrorist attack—and, he explains, it’s erroneous to count those dollars as part of a proposed increase for federal scientific research:
Since these funds have already been appropriated, since they can be spent over a multi-year period, and since only some unknown fraction of them will pay for R&D at all (and only indirectly, at that), they can’t be considered part of the federal governments FY2009 R&D budget.
That’s $2 billion, he points out, that shouldn’t get factored into the modest 1 percent increase, accounting for inflation, in federal R&D support.
Comments on this article
